Released on: May 6, 2008, 7:42 am

Press Release Author: BeyondPR

Industry: Healthcare

Press Release Summary: Autoinjector system is market leader and the "Clear winner"
with patients

Press Release Body: Research undertaken by major international pharmaceutical
clients of The Medical House (TMH) of Sheffield has shown that TMH's disposable
AutoSafety Injector (ASI) autoinjector system is the preferred choice of patients
who need to inject their own medicines. In research trials, the full results of
which are confidential due to their sensitive commercial nature, a clear majority of
patients favoured The Medical House's proprietary technology.

Ian Townsend, Chairman of The Medical House, said: "We are naturally very excited by
these results as they prove to us beyond reasonable doubt what we have known for
some time. Our own autoinjector system is not only an innovative design; patients
really like its simplicity and say they would prefer to use it over alternative
systems.

"This is particularly significant because the continued global growth in uptake of
autoinjector systems requires patients to have confidence in the technology and to
feel it is an easy-to-use, safe and convenient option."

The research found that TMH's ASI was the patients' device of choice, since it can
be properly & comfortably manipulated by patients who suffer from conditions which
make self-injection extremely challenging. TMH's ASI requires only minimal expertise
and dexterity, whilst there is no need to change hand positions during the injection
process, which would prove to be difficult for many patients. In a number of
studies, up to 95% of patients suffering from a range of ailments said they would
use the ASI to inject their drugs, including those whose conditions means that they
may otherwise have been considered unlikely to cope well with self-injection.

The vast majority of respondents felt TMH's ASI was the easiest to use of devices
offered as it has a very intuitive operation, has fewer user steps than alternative
products, and doesn't require any particular strength or expertise to use, making it
suitable for a wide range of patients, including the elderly and those with
conditions which affect their dexterity - such as arthritis. It is not even
necessary to have perfect eyesight to use the ASI. The majority of respondents
considered activation without a button (as is the case with the ASI) preferable to a
device that would require manually pushing a button to make it work.

Ian Townsend adds: "As well as patients, clinicians preferred our ASI device. These
trials indicated that nurses would happily recommend that their patients use our
technology, whereas over a sizeable proportion of nurses stated that would not
recommend alternative technologies to their patients."

TMH's ASI has an intuitive, two-step operation, with no buttons, triggers or catches
to press, and with safe automatic retraction and capture of the used needle.

The multi-centre trials took place in a number of locations in USA and Europe.
ENDS

For further information, or if you would like to discuss your drug delivery
requirements, please contact: Ian Townsend, Chairman, The Medical House PLC, 199
Newhall Road, Sheffield S9 2QJ, United Kingdom. Tel: +44 (0)114 261 9011. Fax:
+44(0) 114 243 1597.
Email: itownsend@themedicalhouse.com
www.themedicalhouse.com



Web Site: http://www.beyondpr.co.uk

Contact Details: Press enquiries:
BeyondPR.
Tel: +44 (0) 114 275 6996.
Mob: +44 (0) 7930 697773.
E-mail:jon.gardner@beyondpr.co.uk
www.beyondpr.co.uk